Related Experiment Videos
Cefixime in the treatment of upper respiratory tract infections and otitis media
1Department of Infectious Diseases, S. Bortolo Hospital, Vicenza, Italy. malinfvi@gpnet.it
Abstract:
An increasing number of clinical failures has been noted after treatment of upper respiratory tract infection and acute otitis media with conventional antibiotics. At present, Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-hemolytic streptococcus (GABHS) are the bacterial pathogens most frequently responsible for these infections. Although GABHS has so far not developed penicillin resistance, the frequency of bacteriological failures with either benzathine penicillin or penicillin V has increased. Firstly, a number of hypotheses have been put forward to explain this, including poor patient compliance and inactivation by beta-lactamase-producing oropharyngeal flora. Secondly, this has added to the demand for new agents to treat resistant streptococci. Cefixime, an orally active third-generation cephalosporin, has attracted considerable attention following the results of numerous clinical studies. Comparative studies between cefixime and conventional antibiotics for the treatment of upper respiratory tract infections and otitis media are summarized.
Insights
Conventional antibiotic treatment failures for respiratory infections are rising. New agents like cefixime are being studied for efficacy against resistant bacteria such as group A beta-hemolytic streptococcus (GABHS).
Area of Science:
- Infectious Diseases
- Pharmacology
- Microbiology
Background:
- Increasing clinical failures observed with conventional antibiotics for upper respiratory tract infections and acute otitis media.
- Key bacterial pathogens include Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and group A beta-hemolytic streptococcus (GABHS).
- Rising rates of bacteriological failures with penicillin treatments for GABHS infections, despite no reported resistance.
Purpose of the Study:
- To summarize comparative studies of cefixime versus conventional antibiotics.
- To evaluate cefixime's efficacy in treating upper respiratory tract infections and otitis media.
- To address the growing need for effective agents against resistant streptococci.
Main Methods:
- Review and summarization of existing clinical studies.
- Comparative analysis of treatment outcomes.
- Focus on orally active third-generation cephalosporins, specifically cefixime.
Main Results:
- Cefixime has shown considerable promise in clinical studies.
- Comparative data highlights cefixime's performance against standard antibiotic treatments.
- Evidence suggests cefixime as a potential alternative for infections caused by resistant bacteria.
Conclusions:
- Conventional antibiotic efficacy is declining for common bacterial infections.
- Cefixime emerges as a significant option for treating respiratory and ear infections.
- Further research and clinical application of cefixime are warranted to combat antibiotic resistance.